Mid-period crossings: the quarter's story is things that started during it and are still completing
The model's full reasoning — Q2 2017 call → NOWe need to determine if the transcript shows both halves: (1) real business activity that started during or around the reported period, narrated as starts, and (2) management conveys that the reported numbers are below the current run rate because the activity started partway through and is still climbing. Let's examine the transcript. The period is Q2 2017. Key events: SPINRAZA launch, biosimilars, aducanumab trials, BIIB092 licensing, BIIB093 acquisition, etc. SPINRAZA: It was approved and launched earlier? The transcript says "We are pleased with the progress we are making with the launch of SPINRAZA as we generated $203 million in revenue in the second quarter." That suggests it's already launched, but the launch started earlier? Actually, SPINRAZA was approved in December 2016, so it's been on the market. But the transcript mentions "significant uptake in the U.S." and "we are now building on this momentum outside the U.S. with recent approvals in Europe, Japan and Canada." So the international launches are new in the period? They say "recent approvals" and "preparing our launch efforts in these markets." So the international launches are not yet transacting? They say "we are preparing our launch efforts" – so not yet started. But they have some ex-U.S. revenue: "$8 million outside the U.S." including "initial launch in the Nordics and named-patient sales in the Middle East and Latin America." So there is some ex-U.S. revenue, but it's small. The main U.S. launch is ongoing. But the question is about "real business activity that crossed from not-happening to happening partway through the period or just around its edges." For SPINRAZA, the U.S. launch was already happening before Q2? Actually, the transcript says "We continue to make solid progress in the U.S. in terms of infrastructure and insurance coverage." And they mention "as of the middle of July, there were 145 sites that have administered SPINRAZA, a significant increase from 88 sites last quarter." So the number of sites increased during the quarter. That suggests more sites started administering during the quarter. But is that a "start"? It's an expansion. The product was already launched. The question is about a new business activity that began. Perhaps the international launches? But they are "preparing" – not yet started. The ex-U.S.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AIN | Albany International Corp. | Q3 2023 | 2023-11-07 | B |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| HLX | Helix Energy Solutions Group, Inc. | Q1 2018 | 2018-04-24 | B+ |
| SBSI | Southside Bancshares, Inc. | Q4 2017 | 2018-02-06 | A |
| ANIP | ANI Pharmaceuticals, Inc. | Q4 2016 | 2017-03-02 | B+ |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
AFL · Q2 2023 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the Japan Post cancer insurance launch in early April, which began selling the product and drove a 60% sales increase as a major contributor. They describe the activity as real and transacting, with Dan Amos noting the significant contribution from the new product. Yoshizumi confirms gradual increase going forward, and Fred highlights runway for more agents and sales calming down after initial jump, indicating the Q2 numbers reflect partial ramp-up rather than full run-rate.
ESE · Q2 2016 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the real mid-period start of Plastique's contribution (acquired partway through Q2, with two months of performance noted and "early performance consistent with our acquisition forecast"), treated as a key new segment. It also explicitly addresses the incomplete climb, noting that the reported Q 2 numbers lag due to partial contribution and that Q3/Q4 will see fuller periods plus seasonality, with the business already running at a higher level as the ramp continues.
PSX · Q4 2016 → YESThe question is about whether management's account of the just-reported period is built substantially around real business activity that crossed from not-happening to happening partway through the per...YES The transcript shows management centering the Q4 story on the Freeport LPG Export Terminal's real start: commissioning completed smoothly, first commercial cargo shipped mid-December (partial Q4 contribution), with full-quarter costs incurred but only partial revenue, and explicit ramp to near-capacity loading in January onward.